Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1DEXMEDETOMIDINE[1] Dexmedetomidine[2] D00514 (Name: Dexmedetomidine),
D01205 (Name: Dexmedetomidine hydrochloride)		[3] ADRA2A,
ADRA2B,
ADRA2C 💬		[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[13] 2, 4, 6, 21, 34, 46, 70, 107, 113, 212, 215, 226, 280
2Dexmedetomidine 1[1] Dexmedetomidine[2] D00514 (Name: Dexmedetomidine),
D01205 (Name: Dexmedetomidine hydrochloride)		[3] ADRA2A,
ADRA2B,
ADRA2C 💬		[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 280
3Dexmedetomidine 2[1] Dexmedetomidine[2] D00514 (Name: Dexmedetomidine),
D01205 (Name: Dexmedetomidine hydrochloride)		[3] ADRA2A,
ADRA2B,
ADRA2C 💬		[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 280
4Dexmedetomidine 3[1] Dexmedetomidine[2] D00514 (Name: Dexmedetomidine),
D01205 (Name: Dexmedetomidine hydrochloride)		[3] ADRA2A,
ADRA2B,
ADRA2C 💬		[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 280
5Dexmedetomidine group[1] Dexmedetomidine[2] D00514 (Name: Dexmedetomidine),
D01205 (Name: Dexmedetomidine hydrochloride)		[3] ADRA2A,
ADRA2B,
ADRA2C 💬		[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 70
6DEXMEDETOMIDINE HYDROCHLORIDE[1] Dexmedetomidine[2] D00514 (Name: Dexmedetomidine),
D01205 (Name: Dexmedetomidine hydrochloride)		[3] ADRA2A,
ADRA2B,
ADRA2C 💬		[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 70
7Dexmedetomidine Hydrochloride Infusion[1] Dexmedetomidine[2] D00514 (Name: Dexmedetomidine),
D01205 (Name: Dexmedetomidine hydrochloride)		[3] ADRA2A,
ADRA2B,
ADRA2C 💬		[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 6
8Dexmedetomidine with ropivacaine[2] Dexmedetomidine,
Ropivacaine		[4] D00514 (Name: Dexmedetomidine),
D01205 (Name: Dexmedetomidine hydrochloride),
D04048 ,
D08490 		[8] ADRA2A,
ADRA2B,
ADRA2C,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		[5] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway 💬[1] 70
9Fentanyl (Low Dose) + Dexmedetomidine[2] Dexmedetomidine,
Fentanyl		[4] D00320 ,
D00514 (Name: Dexmedetomidine),
D01205 (Name: Dexmedetomidine hydrochloride),
D01399 		[4] ADRA2A,
ADRA2B,
ADRA2C,
OPRM1 💬		[4] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 215
10Scopolamine, atropine, edaravone and dexmedetomidine[4] Atropine,
Dexmedetomidine,
Edaravone,
Scopolamine		[9] D00113 ,
D00138 ,
D00514 (Name: Dexmedetomidine),
D01077 ,
D01205 (Name: Dexmedetomidine hydrochloride),
D01552 ,
D02069 ,
D03011 ,
D03814 		[8] ADRA2A,
ADRA2B,
ADRA2C,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		[14] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 2